Jose Luis Guererro

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Keensight Capital SAS (Keensight) is an independent French venture capital firm which was established in 2001. Formerly known as R Capital Management SAS, a subsidiary of the Rothschild Group, the firm became independent in 2013 and changed their name to Keensight Capital. Keensight is located in Paris and manages venture capital investments, including the FCPR R Capital Technologies for a range of clients including European banks, pension schemes, insurance companies, government-controlled entities, fund of funds, family offices and high-net worth private individuals.

Bolton Medical is a leading provider of endovascular solutions for aortic disease based in Miami, US, with 45 million Euros in sales and over 300 employees. Devoted to improve the quality and safety in patient care by developing, manufacturing, and distributing innovative, high quality products and technology solely focused on the aorta to include TAA, AAA, and custom made stent graft systems.

Accriva Diagnostics, Inc. provides point-of-care cardiovascular diagnostics services. It products include avoximeter whole blood oximeter, avoximeter whole blood co-oximeter, data management and connectivity, hemochron response whole blood coagulation system, hemochron signature elite whole blood microcoagulation, inrhythm whole blood system, surgicutt bleeding time, tenderfoot heel incision, tenderlett finger incision device and verifynow system platelet reactivity test. The company is headquartered in San Diego, CA.

Nina Capital SGEIC SA (Nina Capital) is a venture capital firm founded in 2019 by Marta Gaia Zanchi. It is headquartered in Barcelona, Spain.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.